PharmaWeb Healthcare Marketplace

💉 Rasburicase (Rasburicase) 1.5 mg: Powder for solution for injection, 1 vial. This recombinant enzyme is used for the rapid reduction of plasma uric acid levels in cancer patients (pediatric and adult) at risk of tumor lysis syndrome. Rasburicase acts by catalyzing the enzymatic oxidation of uric acid into more soluble metabolites. It is administered via intravenous infusion and only under medical supervision. Made in USA.

💉 Rasburicase (Rasburicase) 1.5 mg Powder for Injection: 1 vial. This medication is used for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies at high risk of developing this syndrome. Rasburicase works by catalyzing the enzymatic oxidation of uric acid into allantoin, a more soluble compound, thereby rapidly reducing plasma uric acid levels. It is administered via intravenous injection and requires a physician's prescription. Made in India.

💉 Rasburicase (Rasburicase) 6mg: Powder for solution for injection, 1 vial — Used for the management of acute hyperuricemia in patients with tumor lysis syndrome during chemotherapy. This medication aids in the elimination of uric acid by converting it to allantoin, facilitating renal excretion. Administered via intravenous infusion and requires a physician's prescription. Made in India.